Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
86,206,897
-
Total 13F shares
-
23,714,176
-
Share change
-
+23,713,476
-
Total reported value
-
$249,192,810
-
Put/Call ratio
-
109%
-
Price per share
-
$10.50
-
Number of holders
-
75
-
Value change
-
+$249,185,371
-
Number of buys
-
74
Institutional Holders of Strata Critical Medical, Inc. - Common Stock, $0.0001 par value per share (SRTA) as of Q2 2021
As of 30 Jun 2021,
Strata Critical Medical, Inc. - Common Stock, $0.0001 par value per share (SRTA) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,714,176 shares.
The largest 10 holders included
HG Vora Capital Management, LLC, ARK Investment Management LLC, VANGUARD GROUP INC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., Raine Capital LLC, BlackRock Inc., RiverPark Advisors, LLC, GEODE CAPITAL MANAGEMENT, LLC, and Deane Retirement Strategies, Inc..
This page lists
75
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.